Management of chronic primary pelvic pain syndromes

B.A. Parsons*, A.P. Baranowski, B. Berghmans, J. Borovicka, A.M. Cottrell, P. Dinis-Oliveira, S. Elneil, J. Hughes, B.E.J. Messelink, A.C.D. Williams, P. Abreu-Mendes, V. Zumstein, D.S. Engeler

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

2 Citations (Web of Science)

Abstract

Management of chronic pelvic pain (CPP) remains a huge challenge for care providers and a major burden for healthcare systems. Treating chronic pain that has no obvious cause warrants an understanding of the difficulties in managing these conditions. Chronic pain has recently been accepted as a disease in its own right by the World Health Organization, with chronic pain without obvious cause being classified as chronic primary pain. Despite innumerable treatments that have been proposed and tried to date for CPP, unimodal therapeutic options are mostly unsuccessful, especially in unselected individuals. In contrast, individualised multimodal management of CPP seems the most promising approach and may lead to an acceptable situation for a large proportion of patients. In the present review, the interdisciplinary and interprofessional European Association of Urology Chronic Pelvic Pain Guideline Group gives a contemporary overview of the most important concepts to successfully diagnose and treat this challenging disease.
Original languageEnglish
Pages (from-to)572-581
Number of pages10
JournalBJU International
Volume129
Issue number5
Early online date27 Oct 2021
DOIs
Publication statusPublished - May 2022

Keywords

  • pain
  • chronic primary pain
  • chronic secondary pain
  • chronic pelvic pain
  • chronic primary pelvic pain syndrome
  • phenotyping
  • primary bladder pain syndrome
  • primary prostate pain syndrome
  • primary scrotal pain syndrome
  • chronic post-surgical pain
  • LOWER URINARY-TRACT
  • INTERSTITIAL-CYSTITIS
  • CHRONIC PROSTATITIS
  • SEXUAL DYSFUNCTION
  • DOUBLE-BLIND
  • MEN
  • CLASSIFICATION
  • POPULATION
  • PREVALENCE
  • EFFICACY

Cite this